◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Linical Co.,Ltd.

Loading...
Price History
Market Data
Market Cap6.3B
P/E Ratio-
P/B Ratio1.12
EPS-23.87
Dividend Yield-
D/E Ratio1.31
Current Ratio1.56
Market SegmentStandard
AccountingJapan GAAP
CurrencyJPY
Business Overview

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Services IT & SERVICES, OTHERS TSE
Key Financial Metrics
10.4B
Revenue
-539.1M
Net Income
-23.87
EPS (Diluted)
550.2M
Free Cash Flow
Profitability
Gross Margin -
Operating Margin -5.6%
Net Profit Margin -5.2%
EBITDA -419.6M
Returns & Efficiency
Return on Assets (ROA) -3.2%
Return on Equity (ROE) -7.4%
Dividend Yield -
EPS -23.87
Financial Health
Total Assets 16.8B
Total Debt 9.5B
Debt to Equity 1.31x
Current Ratio 1.56
Company Info
IndustryIT & SERVICES, OTHERS
Market SegmentStandard
AccountingJapan GAAP
CurrencyJPY
Fiscal Year2025
Peers
8.8T
P/E: 21.3
5.1T
P/E: 14.7
4.5T
P/E: 35.2
2.4T
P/E: 23.1
1.6T
P/E: --
M3,Inc.
2413
1.1T
P/E: 23.8
774.0B
P/E: 20.0
719.1B
P/E: --
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company NameLinical Co.,Ltd.
Ticker2183
ExchangeTSE
SectorServices
IndustryIT & SERVICES, OTHERS
Market SegmentStandard
AccountingJapan GAAP
Fiscal Year2025
CurrencyJPY
Financial Summary
Market Cap6.3B
Revenue10.4B
Net Income-539.1M
P/E Ratio-
EPS-23.87
Net Margin-5.2%
ROE-7.4%
Dividend Yield-
Description

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...